April 2022
The Westover Lab was awarded a grant from The Welch Foundation to develop new targeted drugs to address unmet needs in cancer.
Visit the Welch FoundationFebruary 2022
Dr. Westover was awarded a Cancer Prevention & Research Institute of Texas (CPRIT) Individual Investigator Research grant for "Structures and Targeting of Membrane-Bound RAS Signalsomes in Cancer" totaling over $1M.
Individual Investigator Research grantDecember 2021
Dr. Westover awarded a Developmental Research Program award as part of UTSW’s collaboration with the Developmental and Hyperactive Ras Tumor (DHART) SPORE. The total funding allocation provided by the Simmons Comprehensive Cancer Center was $50,000.
DHART SPORENovember 2021
UTSW findings advance RAS inhibitors for use in fighting more cancers
RAS Inhibitor FindingsNovember 2021
The Westover Lab received a $25,000 Lung SPORE grant to study drug resistance to targeted therapies.
October 2021
Video link to Dr. Westover's talk at ESMO MAP Symposium: Structural basis of direct RAS inhibition
Watch Dr. Westover's TalkOctober 2021
Nature Structural & Molecular Biology: A structural model of a Ras–Raf signalosome
Read the ArticleMarch 2021
Dr. Westover named Translational Pilot Awardee for "KRAS Zygosity as a Biomarker for Lung Cancer Therapy."
April 2019
Cell Chemical Biology: Leveraging compound promiscuity to identify targetable cysteines within the kinome
Read the PublicationJuly 2018
Congressionally Directed Medical Research Programs (CDMRP): Competing for RAS - understanding KRAS and the effects of its interactions for potential lung adenocarcinoma treatment
Read the CDMRP Article